Pecan or Pretzel Snacks for Brain Health in Adults 50+
Official title: Effects of Pecans on Brain Health in Older Americans With Mild Cognitive Impairment: Gut-brain Axis
Run by Texas Tech University Health Sciences Center · NCT07348406 · Data updated 2026-11-12
This study tests whether daily pecan or pretzel snacks for three months can improve memory and mood in people aged 50 and older with cognitive impairment.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Texas Tech University Health Sciences Center Academic / other |
| Locations | 1 site (Lubbock, Texas) |
| Status | Recruiting |
| Started | March 15, 2026 |
| Main results expected | September 30, 2028 |
| Study ends | September 30, 2028 |
| Registry record updated | September 8, 2026 |
| Trial ID | NCT07348406 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 50 and older with cognitive impairment and stable health, not having nut allergies, who are willing to be randomized to a snack-type intervention.
✕Probably not a fit
Individuals with nut allergies, significant untreated medical conditions, or those unlikely to adhere to the snack protocol may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study will randomly assign 60 adults aged 50 and above with cognitive impairment to daily snacking with either pecans or pretzels for three months. Researchers will monitor changes in memory and mood, and will explore potential brain–gut connections by measuring gut bacteria, inflammatory markers, and brain signaling related to the gut–brain axis using fMRI. The trial aims to understand whether snack choice can influence brain function and overall well-being in cognitive impairment. The design includes primary outcomes about cognitive and psychological function, with secondary analyses of biomarkers and gut microbiome changes.
Why it matters
Potential benefit: If successful, participants may experience improvements in memory and mood, with broader insights into dietary strategies for brain health.
How similar studies have gone: Previous work in nutrition and brain health suggests snack type can influence biomarkers and cognition, but this exact pecan versus pretzel approach is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * men and women \> 50 years-old * self-reported IQCODE (informant questionnaire on cognitive decline in the elderly) average score \< 4.5 * self-reported significant functional impairment (related to cognitive impairment) in basic or advanced activities of daily living as evidenced by the Activities of Daily Living (ADLs) questionnaire. If answers to at least one endorsement in the "NO, dependence due to memory concerns". * Stable medications (≥ 12-week unchanged dose before baseline) with no planned changes during trial. * habitually consume less than two servings (2 ozs = 1/4 cup) of nuts or nut spreads per week * willing to accept randomization Exclusion Criteria: * reported nut allergy or intolerance * self-reported untreated hypothyroidism, severe liver disease, or end-stage chronic kidney disease * heavy alcohol drinker: in the past 3 months: men ≥14 drinks/week or women ≥7 drinks/week * recent (\<1 month) appearance of diarrhea or hematochezia before study intervention begins. Rationale: A one-month waiting period after diarrhea or hematochezia (blood in stool) is recommended for a gut microbiome test to ensure the results accurately reflect the state and microbial composition, since diarrhea and hematochezia can significantly alter the gut environment and skew test results. * recent (\<1 month) exposure to antibiotics before study intervention begins. Rationale: A one-month waiting period after antibiotics is recommended for a gut microbiome test because it allows the microbial community time to recover and reach a more stable state, ensuring a more accurate and representative snapshot of the gut microbiome composition, since antibiotic usage can significantly reduce microbial diversity. * Self-reported unstable GI disorder * likeliness of moving during the trial, lack of transportation, or unavailability at sample collection times
Where it's running
-
Texas Tech University Health Sciences Center
Lubbock, Texas, United States Recruiting
Study contacts
- Principal investigator: Chwan-Li (Leslie) Shen, PhD — Texas Tech University Health Sciences Center School of Medicine
- Study coordinator: Chwan-Li (Leslie) Shen, PhD
- Email: leslie.shen@ttuhsc.edu
- Phone: 806-743-2815
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mushroom powder to slow cognitive decline in middle-aged and younger seniors
A randomized trial will test whether daily golden oyster mushroom powder helps maintain cognitive function in adults aged 45–80 who have a family history of dementia or subjective memory concerns.
-
Think Tank nutritional drink to help thinking after stress in middle-aged women.
This trial will test whether taking the 'Think Tank' nutritional drink helps thinking and mood after a physical and psychological stressor in healthy women aged 40–60 who drink caffeine daily.
-
Cannabis abstinence and thinking skills in 15–18-year-olds
We will test whether stopping cannabis use leads to improved thinking and memory in 15–18-year-olds with cannabis dependence or harmful use, with abstinence verified by urine tests.
-
Predicting cognitive test scores from narrated stories using AI
We will test whether an AI program can estimate standard cognitive test scores from short recorded storytelling tasks in people aged 50 and older with memory or thinking concerns.
-
Psilocybin with or without Pimavanserin Pretreatment in Healthy Adults
This study tests whether a single 25 mg dose of psilocybin, given with or without pimavanserin pretreatment or placebo, affects mood and well-being in healthy adults over one month.
-
Gustabor: Tailored AI Nutrition for Taste Changes During Cancer Therapy
This trial tests whether personalized, AI-assisted dietary advice helps people with taste changes from cancer treatment compare to general dietary guidance.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.